New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 24, 2014
06:21 EDTDVADaVita could be weak on Medicare Advantage rates, says Piper Jaffray
Piper Jaffray believes shares of DaVita could be weak today following the release of Medicare's Advance Notice for 2015 Medicare Advantage rates, which it says was worse than expected. Piper notes Preliminary 2015 MA rates were down 7.8% versus expectations for a 6%-7% cut. The firm thinks final rates could improve and recommends buying shares of DaVita on any weakness. Piper maintains an Overweight rating on the stock with a $73 price target.
News For DVA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 11, 2016
16:12 EDTDVADaVita sees 2016 consolidated operating income $1.8B-$1.95B
Sees operating income for Kidney Care for 2016 to be in the range of $1.625B-$1.725B, operating income for HCP for 2016 to be in the range of $175M-$225M and consolidated operating cash flows for 2016 to be in the range of $1.550B-$1.75B.
16:11 EDTDVADaVita reports Q4 EPS ex-items $1.01, consensus 97c
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use